Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results

BACKGROUND: For patients with thromboangiitis obliterans (TAO), revascularization with bypass or angioplasty is frequently not feasible due to the poor outflow of the distal small vessels. We evaluated the long-term results of our experience treating patients with TAO with autologous bone marrow-der...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jianming, Guo, Lianrui, Cui, Shijun, Tong, Zhu, Dardik, Alan, Gu, Yongquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824551/
https://www.ncbi.nlm.nih.gov/pubmed/29471870
http://dx.doi.org/10.1186/s13287-018-0784-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824551/
https://www.ncbi.nlm.nih.gov/pubmed/29471870
http://dx.doi.org/10.1186/s13287-018-0784-6

Ejemplares similares